Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1409744

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1409744

Quit Smoking Drugs Global Market Report 2024

Published: Pre-Order
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Quit Smoking Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quit smoking drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quit smoking drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quit smoking drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Drug Therapy; E-Cigarettes; Nicotine Inhalers; Nicotine Replacement Therapies; Nicotine Sublingual Tablets
  • 2) By Drug: Varenicline (Chantix); Bupropion (Zyban); Other Drugs
  • 3) By Distribution: Drug Store; Online Pharmacies; Retail Pharmacies
  • Companies Mentioned: 22nd Century Group; Alkalon A/S; Cipla Limited; Dr. Reddy's Laboratories; GSK Plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Quit smoking drugs are specialized medications used by individuals aiming to quit smoking. These drugs help reduce cravings and alleviate nicotine withdrawal symptoms. They deliver nicotine in alternative forms, such as chewing gum or patches, for a limited period, thus mitigating withdrawal symptoms and the urge to smoke.

The major products within the category of quit-smoking drugs include drug therapy, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy involves the use of medications to treat or prevent diseases related to smoking cessation. Medications such as Varenicline (Chantix), Bupropion (Zyban), and others are available through various channels, including drug stores, online pharmacies, and retail pharmacies.

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides quit smoking drugs market statistics, including quit smoking drugs industry global market size, regional shares, competitors with a quit smoking drugs market share, detailed quit smoking drugs market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. This quit smoking drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $34.86 billion in 2023 to $39.69 billion in 2024 at a compound annual growth rate (CAGR) of 13.8%. The growth observed in the historical period can be attributed to factors such as health awareness campaigns, advancements in medical treatments, government initiatives, the integration of behavioral therapies, and shifts in consumer attitudes towards smoking cessation.

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $69.08 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The anticipated growth in the forecast period can be attributed to increased investments in research and development, a growing demand for cessation aids, targeted marketing and awareness campaigns, and advancements in pharmacotherapy for smoking cessation. Major trends expected in the forecast period include the adoption of personalized treatment approaches, a rise in health consciousness, the integration of digital therapeutics and apps, the incorporation of behavioral therapy, and the continued emphasis on targeted marketing and education efforts.

The growth of the market for quit-smoking drugs is anticipated to be driven by the increasing prevalence of various diseases associated with smoking. Smoking, the inhalation and exhalation of vapors from burning plant materials such as tobacco, marijuana, and hashish, contributes to numerous health issues. Quit-smoking drugs play a crucial role in reducing the urge to smoke by addressing cravings for tobacco and aiding in the effective cessation of smoking. For instance, as of May 2022, the World Health Organization (WHO) reported that tobacco use is responsible for more than 8 million deaths annually, with over 1.2 million fatalities attributed to non-smokers exposed to secondhand smoke. In the United States alone, cardiovascular disease linked to smoking claims the lives of over 480,000 adults each year, as reported by the American Heart Association in 2021. Thus, the growing prevalence of smoking-related diseases is a significant factor propelling the quit-smoking drug market.

The growth of the quit-smoking drugs market is expected to be further accelerated by the rise of e-commerce. E-commerce, involving the online buying and selling of goods and services, provides a convenient platform for individuals seeking quit-smoking solutions. Quit-smoking drugs are increasingly accessible through online platforms, offering a discreet and user-friendly option for those aiming to quit smoking. For example, in August 2023, the U.S. Census Bureau estimated a 2.1% increase in U.S. retail e-commerce sales for the second quarter of 2023, reaching $277.6 billion. This surge in e-commerce activities contributes to the expansion of the quit-smoking drugs market.

A key trend in the quit-smoking drugs market is the focus on product innovation by major companies to strengthen their market positions. Notably, Swedish Match AB, a tobacco company based in Sweden, introduced ZYN Tobacco Gold in August 2022. ZYN Tobacco Gold is a nicotine pouch with a sweet tobacco flavor, offering a tobacco-free and smoke-free alternative. This innovative product addresses consumer preferences for reduced-risk alternatives, catering to those who wish to avoid tobacco consumption while still enjoying a nicotine kick in smoke-free environments.

Major companies in the quit-smoking drugs market are also concentrating on the development of innovative products such as medicated nicotine lozenges to tackle the high mortality burden associated with smoking. Medicated nicotine lozenges, pharmaceutical products delivering controlled doses of nicotine through oral consumption, aim to assist individuals in quitting smoking by alleviating withdrawal symptoms and reducing the urge to smoke. In May 2021, JB Chemicals & Pharmaceuticals, based in India, launched NOSMOK medicated nicotine lozenges, available in mint flavor with sugar-based or sugar-free variants in 2mg and 4mg strengths. This initiative addresses the significant health and economic costs associated with tobacco use.

In September 2021, Philip Morris International Inc., a U.S.-based tobacco company, acquired Fertin Pharma for $820 million. This strategic acquisition is part of Philip Morris International Inc.'s goal to generate over 50% of its total net revenues from smoke-free products and a minimum of $1 billion in net revenues from products other than nicotine. Fertin Pharma, a Denmark-based pharmaceutical and nutraceutical product manufacturer, brings valuable technologies, expertise, and personnel to support Philip Morris International Inc.'s objectives in the quit-smoking products sector.

Major companies operating in the quit smoking drugs market report are 22nd Century Group, Alkalon A/S, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Laboratoires Pierre Fabre, Takeda Pharmaceutical Company, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., Axsome Therapeutics, BioCorRx Inc., BGP Pharma UAB, Bionorica SE, Cambrex Corporation, Chrono Therapeutics Inc., Coeptis Pharmaceuticals Inc., CV Sciences Inc., D-Pharm Ltd., DURECT Corporation, Egalet Corporation, Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., H&T Presspart Manufacturing Ltd., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp

North America was the largest region in the quit smoking drugs market in 2023. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quit smoking drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11282

Table of Contents

1. Executive Summary

2. Quit Smoking Drugs Market Characteristics

3. Quit Smoking Drugs Market Trends And Strategies

4. Quit Smoking Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Quit Smoking Drugs Market Size and Growth

  • 5.1. Global Quit Smoking Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Quit Smoking Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Quit Smoking Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quit Smoking Drugs Market Segmentation

  • 6.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Therapy
  • E-Cigarettes
  • Nicotine Inhalers
  • Nicotine Replacement Therapies
  • Nicotine Sublingual Tablets
  • 6.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Varenicline (Chantix)
  • Bupropion (Zyban)
  • Other Drugs
  • 6.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Store
  • Online Pharmacies
  • Retail Pharmacies

7. Quit Smoking Drugs Market Regional And Country Analysis

  • 7.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quit Smoking Drugs Market

  • 8.1. Asia-Pacific Quit Smoking Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quit Smoking Drugs Market

  • 9.1. China Quit Smoking Drugs Market Overview
  • 9.2. China Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quit Smoking Drugs Market

  • 10.1. India Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quit Smoking Drugs Market

  • 11.1. Japan Quit Smoking Drugs Market Overview
  • 11.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quit Smoking Drugs Market

  • 12.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quit Smoking Drugs Market

  • 13.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quit Smoking Drugs Market

  • 14.1. South Korea Quit Smoking Drugs Market Overview
  • 14.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quit Smoking Drugs Market

  • 15.1. Western Europe Quit Smoking Drugs Market Overview
  • 15.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quit Smoking Drugs Market

  • 16.1. UK Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quit Smoking Drugs Market

  • 17.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quit Smoking Drugs Market

  • 18.1. France Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quit Smoking Drugs Market

  • 19.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quit Smoking Drugs Market

  • 20.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quit Smoking Drugs Market

  • 21.1. Eastern Europe Quit Smoking Drugs Market Overview
  • 21.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quit Smoking Drugs Market

  • 22.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quit Smoking Drugs Market

  • 23.1. North America Quit Smoking Drugs Market Overview
  • 23.2. North America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quit Smoking Drugs Market

  • 24.1. USA Quit Smoking Drugs Market Overview
  • 24.2. USA Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quit Smoking Drugs Market

  • 25.1. Canada Quit Smoking Drugs Market Overview
  • 25.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quit Smoking Drugs Market

  • 26.1. South America Quit Smoking Drugs Market Overview
  • 26.2. South America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quit Smoking Drugs Market

  • 27.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quit Smoking Drugs Market

  • 28.1. Middle East Quit Smoking Drugs Market Overview
  • 28.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quit Smoking Drugs Market

  • 29.1. Africa Quit Smoking Drugs Market Overview
  • 29.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Quit Smoking Drugs Market Competitive Landscape
  • 30.2. Quit Smoking Drugs Market Company Profiles
    • 30.2.1. 22nd Century Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Alkalon A/S
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cipla Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Dr. Reddy's Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GSK Plc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Quit Smoking Drugs Market Competitive Benchmarking

32. Global Quit Smoking Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

34. Quit Smoking Drugs Market Future Outlook and Potential Analysis

  • 34.1 Quit Smoking Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Quit Smoking Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Quit Smoking Drugs Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!